Testing effectiveness (Phase 2)Study completedNCT03452228
What this trial is testing
Safety and Efficacy Following Repeat-Dose of Evinacumab (Anti-ANGPTL3) in Patients With Severe Hypertriglyceridemia (sHTG) at Risk for Acute Pancreatitis
Who this might be right for
Severe Hypertriglyceridemia (sHTG)
Regeneron Pharmaceuticals 52